Upcoming Events

The AACR Annual Meeting is the critical driver of progress against cancer, the place where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share and discuss the latest breakthroughs. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting showcases cutting-edge cancer science and medicine.

The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the ATMP community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 60+ dedicated presentations by leading publicly traded and privately held companies in the space. Join ARM for Europe’s premier conference for advanced therapies.

The RESI Europe Conference 2025 is coming back to Barcelona! Hosted by Life Science Nation (LSN) in collaboration with Biocat, RESI Europe continues its mission to connect healthcare innovators with global investors and partners. This year’s event features an in-person conference on April 1, 2025, at The InterContinental Barcelona, followed by two days of virtual partnering on April 2-3, 2025.

Part of the globally recognized Redefining Every Stage Investments (RESI) series, this conference offers unparalleled opportunities for life science companies in drugs, devices, diagnostics, and digital health. With 250+ global investors/in-licensors and 250+ life science innovators expected, RESI Europe is your gateway to securing capital, partnerships, and licensing deals.

Build faster and more impactful collaborations with researchers, clinicians, biopharma leaders, investors and policymakers to advance cancer treatments. Hear directly from KOLs on the latest data to help advance and improve outcomes for more patients across a wider range of cancers. Stay ahead of the curve through 100+ multi-dimensional talks covering preclinical research, translational science, clinical development, operational strategies, cell therapy and business advancements.